Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologues While Sparing Paralogous Proteases
Version of Record online: 11 APR 2012
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 7, Issue 7, pages 1173–1176, July 2012
How to Cite
Baeriswyl, V., Rapley, H., Pollaro, L., Stace, C., Teufel, D., Walker, E., Chen, S., Winter, G., Tite, J. and Heinis, C. (2012), Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologues While Sparing Paralogous Proteases. ChemMedChem, 7: 1173–1176. doi: 10.1002/cmdc.201200071
- Issue online: 25 JUN 2012
- Version of Record online: 11 APR 2012
- Manuscript Received: 1 FEB 2012
- Swiss National Science Foundation. Grant Number: PP00P3_123524/1
- Novartis Foundation
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.